Valdecoxib
Valdecoxib was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about possible increased risk of heart attack and stroke.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
314.36
Molecular Formula
C16H14N2O3S
Notes
Research use only, not for human use.
Receptor
COX-2
CAS Number
181695-72-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7033052-01 0.02 mg
Recombinant Polaromonas naphthalenivorans Undecaprenyl-diphosphatase (uppP)
Ask
View Details 
MBS7033052-02 0.1 mg
Recombinant Polaromonas naphthalenivorans Undecaprenyl-diphosphatase (uppP)
Ask
View Details 
MBS7033052-03 5x 0.1 mg
Recombinant Polaromonas naphthalenivorans Undecaprenyl-diphosphatase (uppP)
Ask
View Details 
MBS1067138-01 0.02 mg (E-Coli)
Recombinant Leptospira biflexa serovar Patoc Gamma-glutamyl phosphate reductase (proA)
Ask
View Details MBS1067138-02 0.02 mg (Yeast)
Recombinant Leptospira biflexa serovar Patoc Gamma-glutamyl phosphate reductase (proA)
Ask
View Details MBS1067138-03 0.1 mg (E-Coli)
Recombinant Leptospira biflexa serovar Patoc Gamma-glutamyl phosphate reductase (proA)
Ask
View Details